Autoimmune Diseases  >>  staphylococcal protein A (PRTX-100)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
staphylococcal protein A (PRTX-100) / Protalex
NCT02566603: PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Terminated
1b
15
Europe
PRTX-100, SpA, Staphylococcal Protein A
Protalex, Inc.
Immune Thrombocytopenia
05/18
05/18
NCT00571467: Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Terminated
1
9
RoW
PRTX-100 (Staphylococcal protein A), PRTX-100
Protalex, Inc.
Idiopathic Thrombocytopenic Purpura (ITP)
03/09
03/09
SPARTA, NCT01749787: Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis

Completed
1
61
US
PRTX-100 at 1.5 mcg/kg, Staphylococcal Protein A, SpA, PRTX-100 at 3.0 mcg/kg, PRTX-100 at 6.0 mcg/kg, PRTX-100 at 12.0 mcg/kg, PRTX-100 at 240 mcg, Placebo, PRTX-100 at 420 mcg
Protalex, Inc.
Arthritis, Rheumatoid
08/14
08/14

Download Options